NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TeraDx

TeraDx

Private
ValenciaHealthcare & Life Scienceshttps://teradx.com/

Last Round

Accelerator

Oct 7, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

TeraDx is a biotechnology company that develops microbiome-based diagnostic tools for the early detection of cancer. Its first product is a non-invasive saliva test that uses qPCR analysis and an automated algorithm to identify head and neck cancer in under 24 hours.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

early cancer detectionliquid biopsyhead and neck cancersaliva-based testnon-invasive diagnosticAI diagnosticscancer diagnosticsmicrobial biomarkersdiagnostic algorithmHNSCCmicrobiome diagnosticsoncology diagnosticsqPCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TeraDx Comps

Public and private peers based on sector, stage, and business model.

TeraDx comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TeraDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 7, 2025

TeraDx Investors

Notable investors and investment history

TeraDx investors
InvestorRounds
Zubi LabsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 7, 2025

    Led by Zubi Labs

TeraDx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TeraDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TeraDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersValencia
Year Founded2025
Last FundingOct 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.